Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Finland: Video Shows Fight Between Migrants & Locals, 15yo Finn Beat With 'Hard Object'
Video Shows African Flash Mob 'Flash Rob' Restaurant in Italy
Dr. Drew Show Canceled Just Days After He Questioned Hillary's Health
WATCH: The Truth About the Syrian Boy Viral Photo
WATCH: Sudanese Muslim Refugee Shot After Beating Woman, Cop With Stick -- Media Ignores
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.